China’s Fosun Pharma eyes spin-off Hong Kong IPO of vaccine unit
- Posted on January 23, 2026
- By South China Morning Post
- 4 Views
China’s Fosun Pharma eyes spin-off Hong Kong IPO of vaccine unit
Fosun Adgenvax (Chengdu) joins an IPO wave that raised more than US$1.5 billion last year for biotech companies.
